Advances in the development of vaccines against Marburg and Ebola viruses-Reference-Cited by-同舟云学术

Advances in the development of vaccines against Marburg and Ebola viruses

Published:2007-11 Issue:6 Volume:2 Page:537-541
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Collins Peter L¹,Bukreyev Alexander²

Affiliation:

1. Laboratory of Infectious Disease, National Institute of Allergy & Infectious Diseases, National Institutes of Health, 50 South Drive, Bethesda, MA 20892, USA.

2. Laboratory of Infectious Disease, National Institute of Allergy & Infectious Diseases, National Institutes of Health, 50 South Drive, Room 6505, Bethesda, MA 20892-8007, USA.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/17460794.2.6.537

Reference29 articles.

1. Evaluation in Nonhuman Primates of Vaccines against Ebola Virus

2. Recovery of Infectious Ebola Virus from Complementary DNA: RNA Editing of the GP Gene and Viral Cytotoxicity

3. Rescue of Recombinant Marburg Virus from cDNA Is Dependent on Nucleocapsid Protein VP30

4. Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates

5. OlingerGG, Hart MK: Protective immunity to Ebola infection by Venezuelian equine encephalitis virus replicons expressing Ebola virus proteins.Abstracts of the ICID Global Symposium.Filoviruses: Recent Advances and Future Challenges. International Centre for Infectious Diseases, Winnipeg, Canada, 17–19 September 2006.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge;Virology;2009-01